Institutional Ownership Enlivex Therapeutics Ltd. (ENLV)
This table provides information about the institutional ownership of Enlivex Therapeutics Ltd. (ENLV). We have compiled data on the 32 institutions that hold shares in the stock, with a total of 929,535 shares, which have been reported (via 13F filing form) to have a value of $910,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Red Tortoise LLC
Atlanta, GA |
Oct 22, 2025 Q3 2025 |
150
shares
|
$147
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
125
shares
|
$122
0.0% of portfolio
|
Q3 2025
Reduced 95.89%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
100
shares
|
$98
0.0% of portfolio
|
Q3 2025
Reduced 94.77%
|
|
|
Advisory Services Network, LLC
|
Nov 18, 2025 Q3 2025 |
43
shares
|
$42
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Sargent Bickham Lagudis LLC
|
Jan 23, 2023 Q4 2022 |
15
shares
|
$14
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Nov 04, 2025 Q3 2025 |
1
shares
|
$0
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|